AQR Capital Management’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $240K | Sell |
|
|||||
|
2024
Q3 | $515K | Sell |
|
|||||
|
2024
Q2 | $517K | Buy |
|
|||||
|
2024
Q1 | $148K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $341K | Sell |
|
|||||
|
2023
Q1 | $457K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $270K | Hold |
|
|||||
|
2021
Q2 | $287K | Sell |
|
|||||
|
2021
Q1 | $453K | Sell |
|
|||||
|
2020
Q4 | $499K | Sell |
|
|||||
|
2020
Q3 | $506K | Buy |
|
|||||
|
2020
Q2 | $325K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $201K | Sell |
|
|||||
|
2018
Q2 | $364K | Buy |
|
|||||
|
2018
Q1 | $407K | Buy |
|
|||||
|
2017
Q4 | $460K | Buy |
|
|||||
|
2017
Q3 | $286K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $164K | Sell |
|
|||||
|
2016
Q1 | $265K | Buy |
|
|||||
|
2015
Q4 | $428K | Buy |
|